Jim Cleary named a visionary in hospice and palliative medicine
Jim Cleary, MD, founding medical director of the Palliative Medicine Service at UW Health, was named one of the 30 most influential leaders in hospice and palliative medicine, the medical specialty focused on relieving suffering and improving quality of life for people with serious illnesses.
UW study uses ‘bio-panning’ to find human antibodies for brain cancer stem cells
Using a method described as similar to panning for gold, Carbone Cancer Center scientists discovered human antibodies for the cancer stem cells of glioblastoma, one of the most difficult brain cancers to treat.
UW Carbone oncologist leads effort to educate about cancer risk of alcohol
Drinking alcohol increases the risk of several types of cancer, something many of Dr. Noelle LoConte’s patients are surprised to learn.
Alan Rapraeger awarded $1.9 million grant to study myeloma cell signaling
Alan Rapraeger, MD, professor of human oncology at the University of Wisconsin School of Medicine and Public Health, has been awarded a five-year, $1.9 million R01 grant from the National Cancer Institute to investigate signaling mechanisms that drive myeloma cell proliferation, survival and invasion.
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
Study shows HPV works across cellular borders to drive cervical cancer
Human papillomavirus (HPV) and the hormone estrogen are both linked to the development of cervical cancers, but how they work together has remained unclear.
Zachary Morris earns prestigious NIH Director’s Early Independence Award
The National Institutes of Health (NIH) announced that Dr. Zachary Morris has been awarded $1.25 million as part of the NIH Director’s Early Independence Award.
Study identifies patients who benefit most from dinutuximab-based immunotherapy
Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the Children’s Oncology Group, researchers from the University of Wisconsin School of Medicine and Public Health found that a subset of patients, identified by the presence of a certain set of genes, were more likely to benefit from the immunotherapy than those patients that did not have that set of genes.
UW Carbone Cancer Center researcher receives Komen grant
A UW–Madison researcher has received a grant from the Susan G. Komen Foundation, the world’s leading breast-cancer organization.
Paul Harari begins presidency of radiation oncology society
Dr. Paul Harari of the University of Wisconsin Carbone Cancer Center begins a term this week as president of the American Society for Radiation Oncology (ASTRO), the world’s premier radiation oncology society, which is holding its annual meeting in San Diego.
Q&A: Paul Harari on radiation oncology
Dr. Paul Harari begins his term as president of the American Society for Radiation Oncology (ASTRO) at the group’s annual meeting in San Diego Sept. 24-28.
SPORE announces $400,000 in pilot grants for head and neck cancer
The University of Wisconsin Head and Neck SPORE Grant recently awarded pilot funding to nine UW School of Medicine and Public Health researchers for new projects.